Survival and changes in physical ability after coronary revascularization for octa-nonagenerian patients with acute coronary syndrome

被引:0
|
作者
Kuniyuki Shirasawa
Myung-Woo Hwang
Yoshio Sasaki
Shinichi Takeda
Katsura Inenaga-Kitaura
Yasushi Kitaura
Chuichi Kawai
机构
[1] Ijinkai Takeda General Hospital,Department of Cardiovascular Medicine
[2] Osaka Medical Collage,Third Department of Internal Medicine
来源
Heart and Vessels | 2011年 / 26卷
关键词
Acute coronary syndrome; Elderly populations; Percutaneous coronary intervention; Octo-nonagenerians; Activities of daily living;
D O I
暂无
中图分类号
学科分类号
摘要
Elderly populations are increasingly represented among patients with acute coronary syndrome (ACS), and advanced age has been identified as an important risk factor for death and adverse outcome in patients with ACS treated invasively. Although considerable data have demonstrated a prognostic benefit of early revascularization in ACS particularly in high-risk patients, elderly patients with ACS are treated invasively less often than younger patients because older age is thought to be an independent predictor of mortality after percutaneous coronary intervention (PCI) in ACS. Over the past 5 years, a total of 54 ACS patients over 85 years old were treated. The 6-month survival rate was around 50% in the non-PCI group (n = 12) and around 80% in the PCI group (n = 42) (P < 0.05). Cardiac death occurred in 6 patients in the PCI group and in 6 patients in the non-PCI group. The rates of both cardiac death and all-cause death were significantly lower in the PCI group. The change in ADL score before and 6 months after the procedure was from 1.57 to 1.59 in the PCI group and from 2.25 to 2.20 in the non-PCI group. PCI for elderly patients with ACS is safe and life saving, and does not reduce the ability to perform activities of daily living. PCI should be recommended even for octo-nonagenerians with ACS.
引用
收藏
页码:385 / 391
页数:6
相关论文
共 50 条
  • [31] Coronary intervention in patients with acute coronary syndrome: Does every culprit lesion require revascularization?
    Bangalore S.
    Faxon D.P.
    Current Cardiology Reports, 2010, 12 (4) : 330 - 337
  • [32] The Optimal Timing of Coronary Revascularization in Patients with Acute Heart Failure Syndrome and Coronary Artery Disease
    Inuzuka, Yasutaka
    Kimura, Takeshi
    JOURNAL OF CARDIAC FAILURE, 2012, 18 (10) : S180 - S180
  • [33] ACUTE CORONARY SYNDROME IN RETROVIRAL POSITIVE PATIENTS CHALLENGES AND DILEMMAS WITH SPECIAL EMPHASIS ON CORONARY REVASCULARIZATION
    Setty, Natraj
    Moorthy, Nagaraja
    Raghu, T. R.
    Srinivas, B. C.
    Srinivas, K. H.
    Beeresh, I.
    Ramalingam, Rangaraj
    Kharge, Jayashree
    Manjunath, C. N.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 1277 - 1277
  • [34] Complete Revascularization in Acute and Chronic Coronary Syndrome
    Ilardi, Federica
    Ferrone, Marco
    Avvedimento, Marisa
    Servillo, Giuseppe
    Gargiulo, Giuseppe
    CARDIOLOGY CLINICS, 2020, 38 (04) : 491 - 505
  • [35] Effects of different rehabilitation modality on cardiopulmonary function in patients with acute coronary syndrome after revascularization
    Chen, Wanping
    Feng, Yan
    Yu, Meili
    Zhang, Zhaoguo
    Wu, Jiahui
    Liu, Wenxian
    Gu, Wei
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2024, 10
  • [36] Myocardial revascularization at extremes – surgical revascularization in acute coronary syndrome
    S Kacar
    M Kacar
    Journal of Cardiothoracic Surgery, 8 (Suppl 1)
  • [37] Coronary revascularization in acute coronary syndrome: does the choice of the conduit matter?
    Shahinian, Jasmin H.
    Gurleyen, Mertan
    Grodd, Marlon
    Wolkewitz, Martin
    Beyersdorf, Friedhelm
    Siepe, Matthias
    Pingpoh, Clarence
    JOURNAL OF CARDIOVASCULAR SURGERY, 2021, 62 (06): : 639 - 645
  • [38] Acute Coronary Syndrome Revascularization Strategies With Multivessel Coronary Artery Disease
    Widmer, R. Jay
    Hammonds, Kendall
    Mixon, Timothy
    Exaire, Jose Emilio
    Chiles, Christopher Douglas
    Tavilla, Giuseppe
    Szerlip, Molly I.
    Dimaio, J. Michael
    AMERICAN JOURNAL OF CARDIOLOGY, 2024, 220 : 33 - 38
  • [39] Lipoprotein(a) and the effect of alirocumab on coronary and non -coronary revascularization following acute coronary syndrome
    Steg, P.
    Szarek, M.
    Valgimigli, M.
    Islam, S.
    Zeiher, A. M.
    Bhatt, D. L.
    Bittner, V. A.
    Diaz, R.
    Goodman, S. G.
    Harrington, R. A.
    Jukema, J. W.
    Pordy, R.
    Scemama, M.
    White, H. D.
    Schwartz, G. G.
    EUROPEAN HEART JOURNAL, 2022, 43 : 1386 - 1386
  • [40] CLOPIDOGREL TREATMENT AFTER CORONARY STENTING IN ACUTE CORONARY SYNDROME PATIENTS
    Nasir, Hira
    Khawar, Shanaza
    Hasan, Wazir Muhammad
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (12): : 16132 - 16134